| « Previous month | Next month » |
Syrris has become the primary marketer for Prosonix’s new SonoLab laboratory scale sonocrystallisation and sonoprocessing equipment.
BioTrove has launched a series of assay panels that enable researchers to skip the laborious initial steps of gene selection and assay optimisation and start studying disease pathways straightaway.
UK-based automation expert, Astech Projects, has been signed up to assist a ‘top 5 pharmaceutical company’ just months after launching its new automation maintenance service.
TTP LabTech has transformed its ‘mosquito’ nanolitre liquid handler into a highly flexible system for preparing microplates for high throughput (HT) screening applications.
Phylogeny has launched the first microRNA (miRNA) in situ hybridisation detection service to help scientists delve deeper into the mechanisms controlling key biological processes.
Ion channel expert ChanTest is expanding its range of ion channel services and cell lines that help identify promising target compounds and those that could cause harmful side effects.
European researchers have devised a method of purifying parasites that will enable scientists to gain deeper insights into the biology of the organisms responsible for millions of infections every year.
UK-based deltaDOT has launched a new assay that dramatically reduces the time needed to quantify the number of baculovirus expression vectors present in a sample.
Despite the credit crunch, Invitrogen’s acquisition of ABI (Applied Biosystems) is expected to be complete by early November and details of how the merged entity will be structured have just been released.
UK-based Pharmaceutical Profiles has used an imaging technique known as scintigraphy to quantify the effects of Amylin / Eli Lilly’s latest diabetes drug on the stomach.
Charles River Laboratories has agreed to buy US-based drug discovery imaging expert Molecular Imaging Research, Inc. (MIR) for approximately $12.5m (€8.8m) in cash.
Agilent and Millipore have formed a collaboration to develop fully validated chromatin immunoprecipitation (ChIP) microarray kits that will improve productivity and streamline epigenetic analysis.
Australian proteomics fluorescence expert Fluorotechnics has agreed to buy The Gel Company as part of its strategy to cement itself as a world leader in protein electrophoresis.
Drug discovery informatics and services provider, Tripos International, has agreed to buy Pharsight Corporation, a provider of software and strategic services for clinical drug development.
BioReliance has had to significantly expand its Rockville, US, facility and hire new staff in order to accommodate the growing demand for its genetic toxicology (GeneTox) testing services.
Beleaguered life science tools and services company MDS Inc, has recorded disappointing third quarter results, with revenues from its Analytical Technologies and MDS Pharma Services divisions missing forecasts.
UK analytical services expert, Quotient Bioscience has received a significant equity investment from TA Associates to help further the firm’s acquisition-led and organic growth strategy.
US scientists have discovered a new threat to the US honeybee population using technology developed for detecting viruses on the battlefield.
Tocris Bioscience has launched a new search facility that enables researchers to search for chemicals by the biological targets they work on, rather than the chemical name itself.
UK researchers have developed two synthetic molecules that coax stem cells to differentiate into either neurons or epithelial cells for use in drug discovery applications.
Caliper Life Sciences has launched two new kinase profiling services as well as new assay kits that aim to provide researchers with a better understanding of their kinase inhibitor drug candidates.
| « Previous month | Next month » |